Company / Total Assets
CUMBERLAND PHARMACEUTICALS INC Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$76.8M
FY2025
5-year range
$75.6M / $92.9M
FY2021-FY2025
Trend
+1.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets returned to growth in FY2025 after 2 years of decline, reaching $77M.
Based on SEC 10-K filings.
$77M in FY2025 with a 5-year CAGR of -4.5%.
Declined from $82M to $77M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -6.1%
- 5-Year CAGR
- -4.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -4.5%, indicating a declining trend.
- In FY2025, total assets increased 1.6% year-over-year.
- Peak total assets was recorded in FY2018.
- Lowest total assets in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.11 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $76.8M | +1.6% |
| FY2024 | $75.6M | -7.6% |
| FY2023 | $81.8M | -12.0% |
| FY2022 | $92.9M | +10.0% |
| FY2021 | $84.5M | -12.4% |
| FY2020 | $96.5M | -7.7% |
| FY2019 | $104.5M | -7.2% |
| FY2018 | $112.7M | +20.9% |
| FY2017 | $93.2M | -0.2% |
| FY2016 | $93.4M | +1.6% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026